ALFA FinderBSE filing, NSE: SHRIKRISH. Summary written from the filing by ALFA Finder's alert engine.
Shri Krishna Devcon Ltd: key numbers
- Share price
- ₹36.59
- Market cap
- ₹102.5 Cr
- Revenue (annual)
- ₹21.39 Cr
- Net profit (annual)
- ₹4.56 Cr
- P/E (TTM)
- 25.3×Sector 37.9×
- Promoter holding
- 54.88%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shri Krishna Devcon Ltd
All →Shri Krishna Devcon Other Announcement
Shri Krishna Devcon Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
Shri Krishna Devcon Other Announcement
Shri Krishna Devcon Limited filed the RTA confirmation certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Shri Krishna Devcon Management Change
Shri Krishna Devcon Limited has announced the re-appointment of Mr. Sunil Kumar Jain and Mr. Naveen Kumar Jain as Executive Directors for a three-year term.
Shri Krishna Devcon Price Movement Clarification
Shri Krishna Devcon Limited clarified that recent significant share price movements are purely market-driven. The company confirms no undisclosed price-sensitive information exists currently.
Shri Krishna Devcon Annual General Meeting
Shri Krishna Devcon Ltd held its 32nd AGM via video conferencing. Resolutions included adopting financial statements and re-appointing directors and management.
Shri Krishna Devcon Other Announcement
The company notified exchanges about sending letters to shareholders regarding the Annual Report, KYC updates, and a special physical share transfer window.
Other board meeting date announcements
All →Arvaya Healthcare Board Meeting Date
Arvaya Healthcare Ltd intimated a board meeting on November 13, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The trading window remains closed until 48 hours after results are declared.
Aspire & Innovative Advertising Board Meeting Date
Aspire & Innovative Advertising scheduled a November 14, 2026 board meeting to consider unaudited standalone results for the half year ended September 30, 2026. No results figures are attached yet.
SI Capital & Financial Services Board Meeting Date
S.I. Capital will hold a board meeting on 12 November 2026 to consider unaudited standalone quarterly results. This is a prior intimation for the meeting.
Axel Polymers Board Meeting Date
Axel Polymers will hold a board meeting on 13 November 2026 to consider unaudited half-year results. The trading window stays closed until 48 hours after results.
FlySBS Aviation Board Meeting Date
FlySBS Aviation has scheduled a board meeting for 11 November 2026 to consider unaudited half-yearly results for the period ended September 2026. The trading window is not closed.
Cian Healthcare Board Meeting Date
Cian Healthcare intimated that its board will meet on November 13, 2026, to consider unaudited standalone and consolidated results for the half year ended September 30, 2026. The trading window closes from October 1 until 48 hours after the results.